凯盛科技所属申万行业为：电子-光学光电子-面板。所属概念板块包括：药用玻璃、特种玻璃、 MLED、折叠屏、华为概念等。 截至9月30日，凯盛科技股东户数5.25万，较上期减少18.36%；人均流通股17997股，较上期增加 22.49%。2025年1月-9月，凯盛科技实现营业收入43.10亿元，同比增长20.57%；归母净利润1.29亿元， 同比增长15.06%。 分红方面，凯盛科技A股上市后累计派现4.32亿元。近三年，累计派现1.42亿元。 11月18日，凯盛科技盘中下跌2.02%，截至14:29，报11.67元/股，成交1.29亿元，换手率1.16%，总市值 110.24亿元。 资金流向方面，主力资金净流出1937.38万元，特大单买入0.00元，占比0.00%，卖出898.01万元，占比 6.98%；大单买入1563.59万元，占比12.15%，卖出2602.96万元，占比20.22%。 凯盛科技今年以来股价涨2.73%，近5个交易日跌3.87%，近20日涨0.69%，近60日跌8.11%。 资料显示，凯盛科技股份有限公司位于安徽省蚌埠市黄山大道8009号，成立日期2000年9月30日，上市 日期20 ...

Core Viewpoint - Qibin Group's stock has experienced fluctuations, with a recent decline of 2.08% and a year-to-date increase of 18.42%, indicating volatility in market performance [1][2]. Financial Performance - For the period from January to September 2025, Qibin Group reported a revenue of 11.78 billion yuan, reflecting a year-on-year growth of 1.55%, while the net profit attributable to shareholders was 915 million yuan, showing a significant increase of 30.90% [2]. - Cumulatively, since its A-share listing, Qibin Group has distributed a total of 7.92 billion yuan in dividends, with 1.67 billion yuan distributed over the past three years [3]. Stock Market Activity - As of November 12, Qibin Group's stock price was 6.59 yuan per share, with a market capitalization of 18.375 billion yuan. The trading volume was 119 million yuan, with a turnover rate of 0.64% [1]. - The stock has seen a net outflow of 4.32 million yuan in principal funds, with significant buying and selling activity from large orders [1]. Shareholder Structure - As of October 20, the number of shareholders for Qibin Group was 94,100, a decrease of 3.16% from the previous period, while the average circulating shares per person increased by 3.26% to 28,523 shares [2]. - Notable institutional shareholders include Invesco Great Wall New Energy Industry Fund and GF Advanced Manufacturing Fund, with significant changes in their holdings [3].

Core Viewpoint - Kaisheng Technology's stock has shown a mixed performance in recent trading, with a year-to-date increase of 10.12% and a recent 5-day increase of 5.84% [1] Company Overview - Kaisheng Technology Co., Ltd. is located in Bengbu City, Anhui Province, and was established on September 30, 2000. It was listed on November 8, 2002. The company specializes in the development, research, production, and sales of ITO conductive film glass, online composite coated glass, vacuum coated glass, deep-processed glass products, and new materials [1] - The main business revenue composition is as follows: display materials 79.42%, application materials 17.86%, and others 2.71% [1] Financial Performance - For the period from January to September 2025, Kaisheng Technology achieved an operating income of 4.31 billion yuan, representing a year-on-year growth of 20.57%. The net profit attributable to the parent company was 129 million yuan, with a year-on-year increase of 15.06% [2] - Since its A-share listing, Kaisheng Technology has distributed a total of 432 million yuan in dividends, with 142 million yuan distributed in the last three years [3] Shareholder Structure - As of September 30, 2025, the number of shareholders of Kaisheng Technology was 52,500, a decrease of 18.36% from the previous period. The average circulating shares per person increased by 22.49% to 17,997 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third-largest shareholder with 16.73 million shares, an increase of 7.56 million shares from the previous period [3]

Core Viewpoint - The stock price of Linuo Pharmaceutical Packaging has experienced a decline recently, despite a year-to-date increase, indicating potential volatility in the market [1][2]. Company Overview - Linuo Pharmaceutical Packaging Co., Ltd. is located in Shandong Province, established on March 1, 2002, and listed on November 11, 2021. The company specializes in the research, production, and sales of specialty glass, focusing on borosilicate glass development and application [2]. - The main business revenue composition includes heat-resistant glass (57.02%), pharmaceutical glass (40.74%), and other material sales (2.24%) [2]. Stock Performance - Year-to-date, the stock price has increased by 14.72%, but it has decreased by 2.62% over the last five trading days, 0.12% over the last 20 days, and 20.26% over the last 60 days [2]. - As of October 29, the stock price was reported at 17.12 CNY per share, with a market capitalization of 4.093 billion CNY [1]. Financial Performance - For the period from January to September 2025, Linuo Pharmaceutical Packaging reported a revenue of 721 million CNY, a year-on-year decrease of 13.22%, and a net profit attributable to shareholders of 50.8823 million CNY, down 27.80% year-on-year [2]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 58.60% to 17,600, while the average circulating shares per person decreased by 36.94% to 13,571 shares [2]. - The company has distributed a total of 139 million CNY in dividends since its A-share listing, with 92.177 million CNY distributed over the past three years [3]. Institutional Holdings - As of September 30, 2025, new institutional shareholders include Rongtong Health Industry Flexible Allocation Mixed A/B (holding 3.8 million shares), Green High Dividend Preferred Mixed A (holding 3.1433 million shares), and Yuanxin Yongfeng Pharmaceutical Health A (holding 1.62 million shares) [3].

Core Viewpoint - Linuo Pharmaceutical Packaging Co., Ltd. has experienced fluctuations in stock performance, with a year-to-date increase of 19.08% and a recent decline over the past 60 days of 17.88% [2] Company Overview - Linuo Pharmaceutical Packaging, established on March 1, 2002, and listed on November 11, 2021, is located in Shandong Province, China [2] - The company specializes in the research, production, and sales of specialty glass, focusing on borosilicate glass development and application [2] - Revenue composition includes heat-resistant glass (57.02%), pharmaceutical glass (40.74%), and other material sales (2.24%) [2] - The company operates within the pharmaceutical and biological industry, specifically in medical devices and consumables [2] Financial Performance - For the first half of 2025, Linuo Pharmaceutical reported revenue of 499 million yuan, a year-on-year decrease of 11.07% [2] - The net profit attributable to the parent company was approximately 40.97 million yuan, reflecting a year-on-year decline of 20.12% [2] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 17.08% to 11,100 [2] - The average number of circulating shares per shareholder decreased by 12.16% to 21,522 shares [2] - Cumulative cash dividends since the company's A-share listing amount to 139 million yuan, with 92.18 million yuan distributed over the past three years [3] Institutional Holdings - As of June 30, 2025, notable institutional shareholders include Guotai Junan Value Advantage Flexible Allocation Mixed Fund, which holds 5.90 million shares, a decrease of 1.55 million shares from the previous period [3] - Guotai Junan Innovation Growth Mixed Fund holds 2.87 million shares, down by 530,000 shares [3] - Guotai Junan Pharmaceutical Health Stock A is a new shareholder with 2.79 million shares [3]

Core Viewpoint - Kaisheng Technology's stock has shown a positive trend with a year-to-date increase of 15.32% and a recent 5-day increase of 7.20%, indicating strong market performance and investor interest [1][2]. Company Overview - Kaisheng Technology, established on September 30, 2000, and listed on November 8, 2002, is located in Bengbu City, Anhui Province. The company specializes in the development, production, and sales of ITO conductive film glass, online composite coated glass, vacuum coated glass, deep-processed glass products, and new materials [1]. - The main business revenue composition includes display materials (71.93%), application materials (23.78%), and other supplementary materials (4.29%) [1]. Financial Performance - For the first half of 2025, Kaisheng Technology achieved an operating income of 2.765 billion yuan, representing a year-on-year growth of 24.70%. The net profit attributable to the parent company was 51.5074 million yuan, with a year-on-year increase of 23.70% [2]. - Since its A-share listing, the company has distributed a total of 432 million yuan in dividends, with 142 million yuan distributed in the last three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for Kaisheng Technology was 64,300, a slight decrease of 0.11% from the previous period. The average circulating shares per person increased by 0.11% to 14,693 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 9.1772 million shares (a decrease of 344,100 shares), and Southern CSI 1000 ETF, which holds 6.9674 million shares (an increase of 131,870 shares) [3].